Succimer is a medicine used to treat poisoning from heavy metals like lead or mercury. It works by binding to the metal, making it easier to remove from the body.
Every report comes from a Lived member, sent anonymously.
Have you tried Succimer for Lead Poisoning?
Succimer, sold in the US as Chemet, is a prescription medicine taken by mouth to treat lead poisoning. It is approved for children aged 1 year and older whose blood lead level is above 45 micrograms per deciliter (mcg/dL). Blood lead is measured in these units, and a level that high means a substantial amount of lead is circulating in the body, enough that removing it with medicine, not only stopping the exposure, is recommended. Succimer belongs to a group of medicines called chelating agents, which bind metals so the body can get rid of them. It does not prevent lead poisoning while a child is still exposed, and it is not a treatment for lead encephalopathy, a dangerous swelling of the brain from severe poisoning, which needs hospital care. Specialists sometimes use succimer outside its approval for other metal poisonings, such as mercury or arsenic, where the evidence is more limited. Chelation is sometimes promoted as a heavy metal detox for autism or general health. A systematic review found no trial evidence that it helps autism, and the risks of chelation outweigh any proven benefit for that use. A separate product, Nephroscan, contains a radioactively labeled form of succimer and is used only as an imaging agent for kidney scans.
Lead that enters the body travels in the blood and settles in soft tissues and bones, where it can interfere with the developing brain, blood formation and other organs. Succimer contains sulfur groups that grip lead tightly. Once bound, the lead forms a water-soluble complex that the kidneys can filter into the urine, so blood lead levels fall over days. Succimer mainly reaches lead in the blood and soft tissues. Much of the body's lead is stored in bone and slowly leaks back out, which is why levels often rise again after a course ends. Succimer also increases the loss of zinc in urine, though it has little effect on iron, calcium or magnesium.
Succimer comes as 100 mg capsules. The dose is based on the child's weight and is given every 8 hours for the first 5 days, then every 12 hours for 14 more days, for a full course of 19 days. Starting at a higher dose is not recommended, and taking it continuously for longer than 3 weeks has not been shown to be safe. Capsules should be swallowed whole when possible. For a child who cannot swallow them, the capsule can be opened and the beads inside sprinkled on a small amount of soft food, or put on a spoon followed by a fruit drink. The beads have a strong sulfur-like smell and taste, which some children resist. Keeping the child well hydrated during treatment helps the kidneys clear the bound lead. Before starting, the care team finds and removes the source of lead in the child's home or surroundings. They also check blood lead, a complete blood count, liver tests and kidney function so later results have a baseline. Children who recently had another chelating medicine, edetate calcium disodium, usually wait about four weeks before starting succimer.
Stomach and bowel effects are the most common: nausea, vomiting, diarrhea, loss of appetite and a metallic taste. Some children have tiredness, headache, cold-like symptoms or stomach cramps. Mild rises in liver enzymes show up on blood tests in roughly 6 to 10 percent of people. These are usually temporary and are checked on the weekly blood tests. Succimer can lower neutrophils, the white blood cells that fight infection. This is uncommon, but it is the reason for weekly blood counts. Contact the care team right away if a child develops a fever, chills, sore throat or other signs of infection during treatment, since the medicine may need to be stopped. A rash occurs in about 4 percent of people. Hives, swelling of the face or lips, or blistering sores in the mouth or around the genitals or anus can signal an allergic or skin reaction and should be reported promptly. These reactions can become more likely with each repeated course, and anyone who has had an allergic reaction to succimer should not take it again.
Succimer is not combined with other chelating medicines such as edetate calcium disodium (CaNa2EDTA), an intravenous lead treatment. Tell the care team about all other medicines and supplements. Succimer can affect some lab results. It can make urine ketone strips read falsely positive, and it can make blood uric acid and creatine kinase (CPK, a muscle enzyme) appear falsely low. This matters most for anyone who also tests their urine for ketones, such as people with diabetes, so let other clinicians know about treatment. Animal studies suggest succimer may harm a developing baby. People who could become pregnant should use effective contraception during treatment and for 14 days after the last dose, and anyone pregnant should discuss risks and benefits with the specialist, since lead itself also harms pregnancy. A breastfeeding parent with a blood lead level of 40 mcg/dL or higher is advised to pump and discard milk until the level falls. People with kidney or liver disease need closer monitoring.
Blood lead usually falls substantially within the first days of treatment. Weekly blood tests track blood counts and liver enzymes during the course. After the 19 days, blood lead is rechecked and then followed weekly until it is stable, because lead stored in bone can move back into the blood. A second course is sometimes needed, usually after at least two weeks off treatment. The medicine only works if the exposure stops. Finding and fixing the lead source, such as old paint, dust, soil, water pipes, folk remedies, or lead carried home from a job or hobby, is the main part of care, and lead levels are often monitored for months afterward. It is important to understand what chelation can and cannot do. In a large trial of young children with blood lead levels between 20 and 44 mcg/dL, succimer lowered lead levels but did not improve later learning, behavior or movement compared with placebo. For this reason it is reserved for higher levels, and ongoing developmental follow-up matters for children who have had lead exposure.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Succimer, what you've noticed, or ask the community a question.